Fludarabine plus cyclophosphamide (FC) in patients with previously untreated low-grade lymphoma

被引：0
|
作者：
Dell'Olio, M. [1 ]
La Sala, A. [1 ]
Merla, E. [1 ]
Bodenizza, C. [1 ]
Carella, A. M. [1 ]
Falcone, A. [1 ]
Greco, M. M. [1 ]
Mantuano, S. [1 ]
Melillo, L. [1 ]
Nobile, M. [1 ]
Sanpaolo, G. [1 ]
Scalzulli, P. R. [1 ]
Cascavilla, N. [1 ]
机构：
[1] Casa Sollievo Sofferenza Hosp, IRCCS, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [41] FLT-PET in previously untreated patients with low-grade glioma can predict their overall survival
    Belohlavek, Otakar
    Fencl, Pavel
    Majovsky, Martin
    Jaruskova, Monika
    Benes, Vladimir
    NUCLEAR MEDICINE REVIEW, 2014, 17 (01) : 7 - 12
  • [42] Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia
    Kasamon, YL
    Flinn, IW
    Grever, MR
    Diehl, LF
    Garrett-Mayer, E
    Goodman, SN
    Lucas, MS
    Byrd, JC
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8413 - 8417
  • [43] Transplant-lite using fludarabine-cyclophosphamide (FC) and allogeneic stem cell transplant (AlloSCT) for low grade lymphoma (LGL).
    Khouri, I
    Lee, MS
    Palmer, L
    Giralt, S
    McLaughlin, P
    Korbling, M
    Romaguera, J
    Donato, M
    Younes, A
    Ueno, N
    Gajewski, J
    Cabanillas, F
    Champlin, R
    BLOOD, 1999, 94 (10) : 348A - 348A
  • [44] LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (RETROSPECTIVE STUDY)
    Ionita, H.
    Ionita, I.
    Nicola, D. E.
    Pacurar, R.
    Ionita, C. O.
    Cheveresan, M.
    Borzak, G.
    Ionita, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 523 - 524
  • [45] Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia
    Forconi, Francesco
    Fabbri, Alberto
    Lenoci, Mariapia
    Sozzi, Elisa
    Gozzetti, Alessandro
    Tassi, Maristella
    Raspadori, Donatella
    Lauria, Francesco
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (04) : 247 - 251
  • [46] Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma
    Flinn, Ian W.
    Thompson, Dana S.
    Boccia, Ralph V.
    Miletello, Gerald
    Lipman, Andrew
    Flora, Douglas
    Cuevas, Daniel
    Papish, Steven W.
    Berdeja, Jesus G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (03) : 365 - 373
  • [47] MANAGEMENT OF PATIENTS WITH LOW-GRADE FOLLICULAR LYMPHOMA
    CABANILLAS, FF
    LEE, M
    MCLAUGHLIN, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 81 - 87
  • [48] Combined therapy with rituximab, fludarabine, cyclophosphamide, and dexamethasone (R-FCD) in patients with low-grade-lymphoma.
    Ebeling, P
    Schuett, P
    Seeber, S
    Nowrousian, MR
    BLOOD, 2002, 100 (11) : 296B - 296B
  • [49] Fludarabine monophosphate followed by iodine I 131 tositumomab for untreated low-grade and follicular non-Hodgkin's lymphoma (NHL).
    Leonard, JP
    Coleman, M
    Kostakoglu, L
    Chadburn, A
    Cesarman, E
    Bhatnagar, A
    Tidmarsh, GF
    Kroll, SM
    Goldsmith, SJ
    BLOOD, 1999, 94 (10) : 90A - 90A
  • [50] Fludarabine in combination with idarubicin as treatment of untreated and relapsed low-grade lymphoma. Preliminary results of a multicenter phase II study.
    Kimby, E
    Cavallin-Stahl, E
    Haapaniemi, E
    Hagberg, H
    Osterman, B
    Tullgren, O
    Turesson, I
    Liliemark, J
    BLOOD, 1999, 94 (10) : 95A - 95A
12345